Facaulty of Medicine, Siriraj Hospital
Bangkok, 10700, Thailand
NCT Number: NCT01432522
This study is a preliminary report of pharmacokinetic data of epinephrine administered via intranasal route (IN) comparing with intramuscular (IM) route in healthy adult volunteers.
Looking for future studies?
Notify Me18 year–30 year
All sexes
Interventional
Not applicable
Bangkok, 10700, Thailand
Patients are reluctant to use Epipen® on emergency basis, perhaps because of improperly training, hesitancy and fear of needle. Other route of administration of epinephrine (EPI) may be more benefit such as intranasal route.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: adrenaline
Time frame: predose, 5 , 10, 15, 20, 30, 45, 60, 90, 120, 180 minutes post-dose
Cmax, Area Under Curve, Tmax of epinephrine compare between 0.3 mg intramuscular and 5 mg intranasal route
Time frame: 1 year
Any side effects from such administration such as bad smelling, sorethroat.
Siriraj Hospital
Other
Comparison of Absorption of Epinephrine Into the Circulation After Epinephrine Intranasal Spray Administration and After Intramuscular Injection
Acronym: Epinephrine
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07210320
Anaphylaxis, Food Allergy
St Louis, Missouri, United States
View Trial DetailsNCT02640014
Anaphylaxis, Food Hypersensitivity
Helsinki, Finland
View Trial DetailsNCT07231393
Anaphylaxis, Biphasic Anaphylactic Reaction
View Trial DetailsNCT06065137
Allergic Reaction, Anaphylactic Reaction
Edegem, Antwerp, Belgium
View Trial Details